Mito Red Light Blog

Objectives: The effectiveness of transcranial photobiomodulation (TPBM) in treating anxiety and depression disorders is a demonstrated and identified issue. However, the...

This study was aimed to evaluate the effects of near-infrared (NIR) photobiomodulation (PBM) combined with coenzyme Q10 (CoQ10) on depressive-like behavior,...

Major depressive disorder (MDD) is a prevalent condition associated with high rates of disability, as well as suicidal ideation and...

Transcranial photobiomodulation is an innovative method for the stimulation of neural activity which consists of the exposure of neural tissue...

Background: Anxious-depressive-like behavior has been recognized as an early endophenotype in Alzheimer's disease (AD). Recent studies support early treatment of anxious-depressive-like...

The present study aimed at investigating the antidepressant and antioxidant actions of near-infrared (NIR) laser at a wavelength of 830...

The development of anxiety and depression due to chronic exposure to noise stress has remained as an unsolved health problem...

Background: Major depressive disorder (MDD) is prevalent and has significant impact on individuals and society. Cognitive symptoms are frequent in MDD...

Major depressive disorder (MDD) is a leading cause of disability worldwide with current FDA approved treatments often not providing sustained...

Mood disorders are associated with elevated inflammation, and the reduction of symptoms after multiple treatments is often accompanied by pro-inflammation...

Incompletely treated major depressive disorder (MDD) poses an enormous global health burden. Conventional treatment for MDD consists of pharmacotherapy and...

Background: Transcranial photobiomodulation (tPBM) is a novel, noninvasive, device-based intervention, which has been tested as a possible treatment for various neurological...